Global Oncolytic Virus Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 111

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Oncolytic Virus Therapy market size was valued at USD 6 million in 2023 and is forecast to a readjusted size of USD 28 million by 2030 with a CAGR of 23.8% during review period.

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.

North America and Europe are the main markets, each accounting for about 40% of the market.

The Global Info Research report includes an overview of the development of the Oncolytic Virus Therapy industry chain, the market status of Melanoma (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses), Prostate Cancer (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncolytic Virus Therapy.

Regionally, the report analyzes the Oncolytic Virus Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncolytic Virus Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Oncolytic Virus Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncolytic Virus Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncolytic Virus Therapy market.

Regional Analysis: The report involves examining the Oncolytic Virus Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncolytic Virus Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Oncolytic Virus Therapy:
Company Analysis: Report covers individual Oncolytic Virus Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncolytic Virus Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Melanoma, Prostate Cancer).

Technology Analysis: Report covers specific technologies relevant to Oncolytic Virus Therapy. It assesses the current state, advancements, and potential future developments in Oncolytic Virus Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncolytic Virus Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Oncolytic Virus Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses

Market segment by Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others

Market segment by players, this report covers
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Therapy, with revenue, gross margin and global market share of Oncolytic Virus Therapy from 2019 to 2024.
Chapter 3, the Oncolytic Virus Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncolytic Virus Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Therapy.
Chapter 13, to describe Oncolytic Virus Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oncolytic Virus Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Oncolytic Virus Therapy by Type
        1.3.1 Overview: Global Oncolytic Virus Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Oncolytic Virus Therapy Consumption Value Market Share by Type in 2023
        1.3.3 HSV-based Oncolytic Viruses
        1.3.4 Adenoviruses-based Oncolytic Viruses
        1.3.5 Vaccinia Virus-based Oncolytic Viruses
        1.3.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
        1.3.7 Newcastle Disease Virus-based Oncolytic Viruses
    1.4 Global Oncolytic Virus Therapy Market by Application
        1.4.1 Overview: Global Oncolytic Virus Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Melanoma
        1.4.3 Prostate Cancer
        1.4.4 Breast Cancer
        1.4.5 Ovarian Cancer
        1.4.6 Others
    1.5 Global Oncolytic Virus Therapy Market Size & Forecast
    1.6 Global Oncolytic Virus Therapy Market Size and Forecast by Region
        1.6.1 Global Oncolytic Virus Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Oncolytic Virus Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Oncolytic Virus Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Oncolytic Virus Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Oncolytic Virus Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Oncolytic Virus Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Oncolytic Virus Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Oncolytic Virus Therapy Product and Solutions
        2.1.4 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 Oncolytics Biotech
        2.2.1 Oncolytics Biotech Details
        2.2.2 Oncolytics Biotech Major Business
        2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions
        2.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Oncolytics Biotech Recent Developments and Future Plans
    2.3 Viralytics
        2.3.1 Viralytics Details
        2.3.2 Viralytics Major Business
        2.3.3 Viralytics Oncolytic Virus Therapy Product and Solutions
        2.3.4 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Viralytics Recent Developments and Future Plans
    2.4 Transgene SA
        2.4.1 Transgene SA Details
        2.4.2 Transgene SA Major Business
        2.4.3 Transgene SA Oncolytic Virus Therapy Product and Solutions
        2.4.4 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Transgene SA Recent Developments and Future Plans
    2.5 Oncolys BioPharma
        2.5.1 Oncolys BioPharma Details
        2.5.2 Oncolys BioPharma Major Business
        2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions
        2.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Oncolys BioPharma Recent Developments and Future Plans
    2.6 Targovax
        2.6.1 Targovax Details
        2.6.2 Targovax Major Business
        2.6.3 Targovax Oncolytic Virus Therapy Product and Solutions
        2.6.4 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Targovax Recent Developments and Future Plans
    2.7 PsiOxus Therapeutics
        2.7.1 PsiOxus Therapeutics Details
        2.7.2 PsiOxus Therapeutics Major Business
        2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions
        2.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 PsiOxus Therapeutics Recent Developments and Future Plans
    2.8 SillaJen Biotherapeutics
        2.8.1 SillaJen Biotherapeutics Details
        2.8.2 SillaJen Biotherapeutics Major Business
        2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions
        2.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 SillaJen Biotherapeutics Recent Developments and Future Plans
    2.9 Sorrento Therapeutics
        2.9.1 Sorrento Therapeutics Details
        2.9.2 Sorrento Therapeutics Major Business
        2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions
        2.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Sorrento Therapeutics Recent Developments and Future Plans
    2.10 Lokon Pharma
        2.10.1 Lokon Pharma Details
        2.10.2 Lokon Pharma Major Business
        2.10.3 Lokon Pharma Oncolytic Virus Therapy Product and Solutions
        2.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Lokon Pharma Recent Developments and Future Plans
    2.11 Genelux Corporation
        2.11.1 Genelux Corporation Details
        2.11.2 Genelux Corporation Major Business
        2.11.3 Genelux Corporation Oncolytic Virus Therapy Product and Solutions
        2.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Genelux Corporation Recent Developments and Future Plans
    2.12 Vyriad
        2.12.1 Vyriad Details
        2.12.2 Vyriad Major Business
        2.12.3 Vyriad Oncolytic Virus Therapy Product and Solutions
        2.12.4 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Vyriad Recent Developments and Future Plans
    2.13 TILT Biotherapeutics
        2.13.1 TILT Biotherapeutics Details
        2.13.2 TILT Biotherapeutics Major Business
        2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions
        2.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 TILT Biotherapeutics Recent Developments and Future Plans
    2.14 Cold Genesys
        2.14.1 Cold Genesys Details
        2.14.2 Cold Genesys Major Business
        2.14.3 Cold Genesys Oncolytic Virus Therapy Product and Solutions
        2.14.4 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Cold Genesys Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Oncolytic Virus Therapy by Company Revenue
        3.2.2 Top 3 Oncolytic Virus Therapy Players Market Share in 2023
        3.2.3 Top 6 Oncolytic Virus Therapy Players Market Share in 2023
    3.3 Oncolytic Virus Therapy Market: Overall Company Footprint Analysis
        3.3.1 Oncolytic Virus Therapy Market: Region Footprint
        3.3.2 Oncolytic Virus Therapy Market: Company Product Type Footprint
        3.3.3 Oncolytic Virus Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Oncolytic Virus Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Oncolytic Virus Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Oncolytic Virus Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Oncolytic Virus Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Oncolytic Virus Therapy Consumption Value by Type (2019-2030)
    6.2 North America Oncolytic Virus Therapy Consumption Value by Application (2019-2030)
    6.3 North America Oncolytic Virus Therapy Market Size by Country
        6.3.1 North America Oncolytic Virus Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Oncolytic Virus Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Oncolytic Virus Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Oncolytic Virus Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Oncolytic Virus Therapy Market Size by Country
        7.3.1 Europe Oncolytic Virus Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Oncolytic Virus Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Oncolytic Virus Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Oncolytic Virus Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region
        8.3.1 Asia-Pacific Oncolytic Virus Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Oncolytic Virus Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Oncolytic Virus Therapy Consumption Value by Type (2019-2030)
    9.2 South America Oncolytic Virus Therapy Consumption Value by Application (2019-2030)
    9.3 South America Oncolytic Virus Therapy Market Size by Country
        9.3.1 South America Oncolytic Virus Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Oncolytic Virus Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Oncolytic Virus Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Oncolytic Virus Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country
        10.3.1 Middle East & Africa Oncolytic Virus Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Oncolytic Virus Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Oncolytic Virus Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Oncolytic Virus Therapy Market Drivers
    11.2 Oncolytic Virus Therapy Market Restraints
    11.3 Oncolytic Virus Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Oncolytic Virus Therapy Industry Chain
    12.2 Oncolytic Virus Therapy Upstream Analysis
    12.3 Oncolytic Virus Therapy Midstream Analysis
    12.4 Oncolytic Virus Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oncolytic Virus Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Oncolytic Virus Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Oncolytic Virus Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Oncolytic Virus Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Amgen Company Information, Head Office, and Major Competitors
    Table 6. Amgen Major Business
    Table 7. Amgen Oncolytic Virus Therapy Product and Solutions
    Table 8. Amgen Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Amgen Recent Developments and Future Plans
    Table 10. Oncolytics Biotech Company Information, Head Office, and Major Competitors
    Table 11. Oncolytics Biotech Major Business
    Table 12. Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions
    Table 13. Oncolytics Biotech Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Oncolytics Biotech Recent Developments and Future Plans
    Table 15. Viralytics Company Information, Head Office, and Major Competitors
    Table 16. Viralytics Major Business
    Table 17. Viralytics Oncolytic Virus Therapy Product and Solutions
    Table 18. Viralytics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Viralytics Recent Developments and Future Plans
    Table 20. Transgene SA Company Information, Head Office, and Major Competitors
    Table 21. Transgene SA Major Business
    Table 22. Transgene SA Oncolytic Virus Therapy Product and Solutions
    Table 23. Transgene SA Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Transgene SA Recent Developments and Future Plans
    Table 25. Oncolys BioPharma Company Information, Head Office, and Major Competitors
    Table 26. Oncolys BioPharma Major Business
    Table 27. Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions
    Table 28. Oncolys BioPharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Oncolys BioPharma Recent Developments and Future Plans
    Table 30. Targovax Company Information, Head Office, and Major Competitors
    Table 31. Targovax Major Business
    Table 32. Targovax Oncolytic Virus Therapy Product and Solutions
    Table 33. Targovax Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Targovax Recent Developments and Future Plans
    Table 35. PsiOxus Therapeutics Company Information, Head Office, and Major Competitors
    Table 36. PsiOxus Therapeutics Major Business
    Table 37. PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions
    Table 38. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. PsiOxus Therapeutics Recent Developments and Future Plans
    Table 40. SillaJen Biotherapeutics Company Information, Head Office, and Major Competitors
    Table 41. SillaJen Biotherapeutics Major Business
    Table 42. SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions
    Table 43. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. SillaJen Biotherapeutics Recent Developments and Future Plans
    Table 45. Sorrento Therapeutics Company Information, Head Office, and Major Competitors
    Table 46. Sorrento Therapeutics Major Business
    Table 47. Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions
    Table 48. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Sorrento Therapeutics Recent Developments and Future Plans
    Table 50. Lokon Pharma Company Information, Head Office, and Major Competitors
    Table 51. Lokon Pharma Major Business
    Table 52. Lokon Pharma Oncolytic Virus Therapy Product and Solutions
    Table 53. Lokon Pharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Lokon Pharma Recent Developments and Future Plans
    Table 55. Genelux Corporation Company Information, Head Office, and Major Competitors
    Table 56. Genelux Corporation Major Business
    Table 57. Genelux Corporation Oncolytic Virus Therapy Product and Solutions
    Table 58. Genelux Corporation Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Genelux Corporation Recent Developments and Future Plans
    Table 60. Vyriad Company Information, Head Office, and Major Competitors
    Table 61. Vyriad Major Business
    Table 62. Vyriad Oncolytic Virus Therapy Product and Solutions
    Table 63. Vyriad Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Vyriad Recent Developments and Future Plans
    Table 65. TILT Biotherapeutics Company Information, Head Office, and Major Competitors
    Table 66. TILT Biotherapeutics Major Business
    Table 67. TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions
    Table 68. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. TILT Biotherapeutics Recent Developments and Future Plans
    Table 70. Cold Genesys Company Information, Head Office, and Major Competitors
    Table 71. Cold Genesys Major Business
    Table 72. Cold Genesys Oncolytic Virus Therapy Product and Solutions
    Table 73. Cold Genesys Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Cold Genesys Recent Developments and Future Plans
    Table 75. Global Oncolytic Virus Therapy Revenue (USD Million) by Players (2019-2024)
    Table 76. Global Oncolytic Virus Therapy Revenue Share by Players (2019-2024)
    Table 77. Breakdown of Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Oncolytic Virus Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 79. Head Office of Key Oncolytic Virus Therapy Players
    Table 80. Oncolytic Virus Therapy Market: Company Product Type Footprint
    Table 81. Oncolytic Virus Therapy Market: Company Product Application Footprint
    Table 82. Oncolytic Virus Therapy New Market Entrants and Barriers to Market Entry
    Table 83. Oncolytic Virus Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Oncolytic Virus Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 85. Global Oncolytic Virus Therapy Consumption Value Share by Type (2019-2024)
    Table 86. Global Oncolytic Virus Therapy Consumption Value Forecast by Type (2025-2030)
    Table 87. Global Oncolytic Virus Therapy Consumption Value by Application (2019-2024)
    Table 88. Global Oncolytic Virus Therapy Consumption Value Forecast by Application (2025-2030)
    Table 89. North America Oncolytic Virus Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 90. North America Oncolytic Virus Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 91. North America Oncolytic Virus Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. North America Oncolytic Virus Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. North America Oncolytic Virus Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 94. North America Oncolytic Virus Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 95. Europe Oncolytic Virus Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Europe Oncolytic Virus Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Europe Oncolytic Virus Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 98. Europe Oncolytic Virus Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 99. Europe Oncolytic Virus Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Oncolytic Virus Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Oncolytic Virus Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 102. Asia-Pacific Oncolytic Virus Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 103. Asia-Pacific Oncolytic Virus Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 104. Asia-Pacific Oncolytic Virus Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 105. Asia-Pacific Oncolytic Virus Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 106. Asia-Pacific Oncolytic Virus Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 107. South America Oncolytic Virus Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 108. South America Oncolytic Virus Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 109. South America Oncolytic Virus Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 110. South America Oncolytic Virus Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 111. South America Oncolytic Virus Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. South America Oncolytic Virus Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Middle East & Africa Oncolytic Virus Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Oncolytic Virus Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 115. Middle East & Africa Oncolytic Virus Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 116. Middle East & Africa Oncolytic Virus Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Oncolytic Virus Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 118. Middle East & Africa Oncolytic Virus Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 119. Oncolytic Virus Therapy Raw Material
    Table 120. Key Suppliers of Oncolytic Virus Therapy Raw Materials
List of Figures
    Figure 1. Oncolytic Virus Therapy Picture
    Figure 2. Global Oncolytic Virus Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Oncolytic Virus Therapy Consumption Value Market Share by Type in 2023
    Figure 4. HSV-based Oncolytic Viruses
    Figure 5. Adenoviruses-based Oncolytic Viruses
    Figure 6. Vaccinia Virus-based Oncolytic Viruses
    Figure 7. Vesicular Stomatitis Virus-based Oncolytic Viruses
    Figure 8. Newcastle Disease Virus-based Oncolytic Viruses
    Figure 9. Global Oncolytic Virus Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 10. Oncolytic Virus Therapy Consumption Value Market Share by Application in 2023
    Figure 11. Melanoma Picture
    Figure 12. Prostate Cancer Picture
    Figure 13. Breast Cancer Picture
    Figure 14. Ovarian Cancer Picture
    Figure 15. Others Picture
    Figure 16. Global Oncolytic Virus Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 17. Global Oncolytic Virus Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 18. Global Market Oncolytic Virus Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 19. Global Oncolytic Virus Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 20. Global Oncolytic Virus Therapy Consumption Value Market Share by Region in 2023
    Figure 21. North America Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East and Africa Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Oncolytic Virus Therapy Revenue Share by Players in 2023
    Figure 27. Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 28. Global Top 3 Players Oncolytic Virus Therapy Market Share in 2023
    Figure 29. Global Top 6 Players Oncolytic Virus Therapy Market Share in 2023
    Figure 30. Global Oncolytic Virus Therapy Consumption Value Share by Type (2019-2024)
    Figure 31. Global Oncolytic Virus Therapy Market Share Forecast by Type (2025-2030)
    Figure 32. Global Oncolytic Virus Therapy Consumption Value Share by Application (2019-2024)
    Figure 33. Global Oncolytic Virus Therapy Market Share Forecast by Application (2025-2030)
    Figure 34. North America Oncolytic Virus Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 35. North America Oncolytic Virus Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 36. North America Oncolytic Virus Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 38. Canada Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 39. Mexico Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 40. Europe Oncolytic Virus Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 41. Europe Oncolytic Virus Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 42. Europe Oncolytic Virus Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 44. France Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 45. United Kingdom Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 46. Russia Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 47. Italy Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Oncolytic Virus Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Oncolytic Virus Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Oncolytic Virus Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 51. China Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 52. Japan Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 53. South Korea Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 54. India Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 55. Southeast Asia Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 56. Australia Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 57. South America Oncolytic Virus Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 58. South America Oncolytic Virus Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 59. South America Oncolytic Virus Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 60. Brazil Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 61. Argentina Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 62. Middle East and Africa Oncolytic Virus Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 63. Middle East and Africa Oncolytic Virus Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 64. Middle East and Africa Oncolytic Virus Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 65. Turkey Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 66. Saudi Arabia Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 67. UAE Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 68. Oncolytic Virus Therapy Market Drivers
    Figure 69. Oncolytic Virus Therapy Market Restraints
    Figure 70. Oncolytic Virus Therapy Market Trends
    Figure 71. Porters Five Forces Analysis
    Figure 72. Manufacturing Cost Structure Analysis of Oncolytic Virus Therapy in 2023
    Figure 73. Manufacturing Process Analysis of Oncolytic Virus Therapy
    Figure 74. Oncolytic Virus Therapy Industrial Chain
    Figure 75. Methodology
    Figure 76. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

Related Reports

Global Oncolytic Virus Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Oncolytic Virus Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 05 Jun 2021

date Medical Care

The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Oncolytic Virus Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Oncolytic Virus Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Medical Care

Global Oncolytic Virus Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Oncolytic Virus Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

Global Oncolytic Virus Therapy Supply, Demand and Key Producers, 2024-2030

Global Oncolytic Virus Therapy Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Medical Care

The global Oncolytic Virus Therapy market size is expected to reach $ 28 million by 2030, rising at a market growth of 23.8% CAGR during the forecast period (2024-2030).

Product Tags

oncolytic virus therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>